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The discovery of a homolog of the retinoblastoma
protein (Rb) in a single-celled eukaryote — the alga
Chlamydomonas – promises new and surprising
insights into Rb’s function in cell-cycle regulation.
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The retinoblastoma gene (Rb) entered the biological
limelight when it was the first gene found to be mutated
in an inherited human cancer syndrome [1], and soon after
it was found to be targeted for inactivation by the oncopro-
teins of certain DNA tumor viruses [2]. These observa-
tions pointed to a pivotal role for the Rb protein in
preventing tumorigenesis. Indeed, subsequent work has
shown that the pathway containing Rb and its regulators is
mutated in the vast majority of all human tumors [3]. In
normal cells, Rb becomes hyperphosphorylated and inacti-
vated during the cell cycle at a time that correlates with
acquisition of mitogen independence [4], the so-called G1
restriction or ‘R’ point [5].
Rb is thus also a part of the normal pathway by which
mitogens regulate cell proliferation. Rb functions as a cell-
cycle regulator primarily by inhibiting the transcription of
many genes, including cyclins and DNA replication pro-
teins. Rb works by binding to the family E2F transcription
factors, and the Rb–E2F complex acts directly at promot-
ers as a transcription repressor. The Rb–E2F interaction is
negatively regulated by cyclin-dependent kinase hyper-
phosphorylation of Rb. Separation of Rb from E2F not
only relieves transcriptional repression by this complex,
but also frees E2F to act as a direct transcriptional activa-
tor. Rb thus provides a link between cyclin-dependent
kinases and cell-cycle-regulated gene expression, and
between cell-cycle control and tumorigenesis.
Rb homologs have been found in all animal genomes
sequenced, and also in plants. It is interesting that the first
plant Rb protein identified, maize Rb, was shown to be
targeted by the RepA protein of the plant geminivirus, and
this was found to be important for efficient viral DNA
replication [6,7]. This is similar to the interaction between
animal cell Rb and animal viruses, and implied that plant
and Rb proteins have at least some conserved functions.
Now an Rb homolog has been identified in a single-celled
organism — the alga Chlamydomonas [8]. The functional
characterization of Chlamydomonas Rb provides the clearest
evidence yet that a plant Rb protein functions to
negatively regulate cell-cycle decisions. 
The Chlamydomonas mat3 gene captured the interest of
Umen and Goodenough [8] because mutations in it were
found to cause Chlamydomonas cells to become unusually
small. In other single-celled organisms, the small size
phenotype has turned out to be a very specific indication
of alterations in cell-cycle regulation — this is true, for
example, of the wee mutations in fission yeast [9] and of
dominant CLN3 mutations in budding yeast [10]. Remark-
ably, this also turned out to be true for Chlamydomonas,
because the mat3 gene turns out to encode a clear algal Rb
homolog, including signature sequences consistent with
interaction with E2F and D-type cyclins.
Chlamydomonas is a photosynthetic organism that exhibits
two forms of cell-size control on the division cycle, and
deletion of mat3 (Rb) affects both of them. When prolifer-
ating in light, Chlamydomonas cells must first grow to a
critical size in order to become committed to complete the
cell-division cycle. Commitment, in this case, means that
the cell will complete the cell cycle — S phase and mitosis
— even if it is placed in darkness where further cell
growth will cease. Mutant mat3 cells do this at a substan-
tially smaller size than wild-type cells. This kind of control
is observed in many organisms, and allows coordination of
growth and division. 
A peculiarity of Chlamydomonas is that, for unclear reasons,
some cells can grow substantially greater than the minimum
commitment size. In order to achieve size homeostasis, these
larger cells will undergo not one but several rapid sequential
rounds of DNA replication and cell division (S/M cycles with
no intervening time for cell growth). It is thus thought that
there is a second decision where it is determined how many
rapid (S/M) division cycles will be executed such that the
final daughter cell size will be fairly constant. These rapid
divisions can occur in the dark or light, although normal
circadian timing ensures that the divisions will happen in
the dark and in the absence of further cell growth. Mutant
mat3 cells are also affected in this process, because they go
through more post-commitment divisions than wild-type
cells — despite being smaller to start with — and thereby
end up much smaller than normal.
Umen and Goodenough [8] compare the initial commit-
ment to the cell cycle after the critical size is reached to
Dispatch R825
the ‘Start’ commitment point in budding yeast, and to the
restriction point in animal cells. This is an exciting
proposal, because it would offer an opportunity to study
how Rb regulates cell-cycle commitment in a simplified
microbial setting. 
One difficulty is that the yeast Start and animal cell R
point are not clearly the same. In budding yeast, Start —
often thought of as a commitment to cell division —
represents the point in the cell cycle where growth is
coordinated with division, resulting in apparent cell ‘size
control’. In mammalian cells, passage through the R point
is experimentally defined in terms of a transition to
mitogen independence. Because Start and the R point are
often thought of as physiologically analogous events, it is
usually assumed that mammalian cell size is also
controlled at the R point, but this may not be so.
Zetterberg and Larson [11] have shown, using time-lapse
cinematography of single cells, that the transition to
mitogen independence — the R point — occurs after an
invariant post-mitotic interval, during which time cell
growth is not required and often does not even occur.
Thus the R point, and possibly Rb as well, may not have a
great deal to do with cell-size control. It has never been
clearly resolved whether there might be a second control
point in G1 that is growth- or cell-size-dependent,
although it is clear that early activation of G1 cyclins can
shorten G1 and reduce cell size in animal cells as in yeast.
For free-living single-celled organisms such as budding
yeast and Chlamydomonas, the crucial parameter in deter-
mining whether cell division can be completed (or should
be attempted) is the supply of nutrients (or light, for
Chlamydomonas) in the environment. These cells presum-
ably take every chance to divide when enough food is
available. Commitment to cell division will therefore
hinge on whether or not the nutrient supply is adequate.
In contrast, nutrient supply is almost always more than
adequate for cells in a multicellular organism. Much more
critical is the requirement that proliferation is properly
coordinated among populations of cells — in developmen-
tal patterning, for example — and this is largely dictated
by extracellular signals such as growth factors and antimi-
togens. From this physiological perspective, the commit-
ment decision in Chlamydomonas could be more related to
Start in budding yeast than to the mammalian R point,
because in budding yeast and Chlamydomonas commitment
is a ‘size-based’ decision. Thus, the regulation of commit-
ment in Chlamydomonas may not be a good model for R
point control in mammalian cells.
Even though the overlying physiology of G1 commitment
is probably not conserved, the underlying molecular path-
ways still might be (see Figure 1). Budding yeast Start is
best understood at the molecular level as the production of
a sufficient amount of ‘G1 cyclins’, encoded by the CLN
genes [12]. In a proposed mechanism for cell-size control
[13], G1 cyclins are produced in proportion to the number
of cytoplasmic ribosomes, but then may accumulate in a
constant-volume nucleus, leading to a size-dependent
concentration increase. A sufficient nuclear concentration
of G1 cyclins results in cell-cycle commitment both by
triggering expression of the downstream B-type (S/M)
cyclins, and by inactivating inhibitors of B-type
cyclin–cyclin-dependent kinase (Cdk) kinase activity,
such as Sic1. G1 cyclin overproduction strongly reduces
cell size in budding yeast, perhaps because the extra G1
cyclin protein is misread by the system as indicating a
much larger cell size or protein biosynthetic capacity than
is actually present.
In mammalian cells, the molecular correlates of the R
point, with respect to Rb, E2F, cyclins, inhibitors and so
on, remain unclear. The temporal correlation between Rb
phosphorylation and passage through the R point first
suggested a causal connection [4]. A reasonable model,
and one that has close analogy to the situation in budding
yeast, is that mitogen-dependent accumulation and activa-
tion of D-type cyclin–Cdk complexes within the nucleus
underlies commitment [14]. Cyclin D–Cdk complexes
enable expression and activation of the downstream G1/S
(E/A-type) cyclins, in part by phosphorylating and inacti-
vating Rb, and in part by sequestering the Cdk inhibitors
p27Kip1 and p21Cip1. 
Standing in apparent contradiction to this idea is the
observation that Rb null mammalian cells show no sign of
having lost the mitogen requirement for cell-cycle
commitment [15]. Further analyses, however, have
revealed that cells that are mutant for both Rb and p21Cip1
[16], or cells that are mutant for all three Rb family
members — Rb, p107 and p130 — do show significant
mitogen-independent cell proliferation [17]. Thus, Rb (or
the Rb family) does seem to contribute to mitogen-depen-
dent proliferation, but the relationship is not a simple one
and the mechanism by which this is accomplished remains
uncertain.
It is reasonable to expect some similarities between cell
cycle commitment in Chlamydomonas and that in yeast or
mammalian cells. One way that deletion of mat3 might
result in the described phenotypes, based on yeast work
and the idea that Rb is a transcriptional repressor, would
be for Mat3 to directly control commitment by repressing
transcription of something equivalent to G1 cyclins. If
mat3 deletion increases G1 cyclin expression, the nuclear-
cytoplasmic ratio would be misread, and cell size would
decrease. An alternative point of view, and one that is
more similar to the situation in mammalian cells, would be
for Rb to indirectly control commitment by repressing
expression of a downstream G1/S cyclin(s). The mat3
mutation, by removing one constraint on G1/S cyclin
expression, might in this case result in a lesser amount of
G1 cyclin being sufficient for commitment. This would
have the effect of decreasing the growth requirement and
therefore reducing cell size.
It is difficult at this point to choose between these models,
primarily because nothing is known about cyclins in
Chlamydomonas. But as Chlamydomonas is related to plants
(more than to yeast), it is likely to have a plant-like
complement of A, B and D-type cyclins. No obvious E-
type cyclin gene has been identified in the complete
Arabidopsis genome sequence, but it is possible that some
A-type cyclins, which are close cyclin E homologs, may
perform cyclin E biological roles in plants. The control of
accumulation and activity of such cyclins in Chlamy-
domonas by cell size and Rb is likely to be interesting to
study.
In addition to the involvement of mat3 in commitment,
Umen and Goodenough [8] conclude that Mat3 is also
independently involved in the second cell-size-related
decision, where it is determined how many rapid (S/M)
division cycles will be executed once commitment is
established. An entertaining, although possibly specious,
analogy can be made to the early embryonic cell cycle,
where cell growth occurs during oogenesis, and is
completely separated from the rapid post-fertilization cell
cycles, which proceed without any cell growth require-
ment, although cyclin synthesis is still required [18]. The
nuclear-cytoplasmic ratio appears to be important in
determining the number of rapid embryonic cell cycles
[19]. The near-constancy of the final cell volume of
Chlamydomonas daughter cells could indicate a reading of
nuclear-cytoplasmic ratio, which once again could be
misread in the mat3 mutant if expression of certain cyclins
were derepressed. It is possible, therefore, that the two
apparently independent size controls in Chlamydomonas
may in fact be perturbed by loss of Rb by the same
mechanism.
A last interesting point raised by Umen and Goodenough
[8] is that cell-cycle control in plants and in Chlamydomonas
may be closer to that in animal cells than in either budding
or fission yeast. Conventional evolutionary trees indicate
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Figure 1
Models for cell cycle commitment in
mammalian cells (top), budding yeast (middle)
and Chlamydomonas (bottom). The differing
shades of green represent differing levels of
G1 cyclin accumulation in the nucleus. Arrows
emanating from the dark green nucleus
indicate direct actions of the G1 cyclins. A
blue nucleus indicates the functional switch
from G1 cyclins to cyclins activating DNA
replication (cyclins E/A in mammals and the
CLB cyclins in yeast). The Chlamydomonas
model is almost entirely speculative and based
on analogy to the other systems.
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that plants, animals and yeast are about equally distantly
related, and yet plants and animals, but not yeast, contain
Rb, D-type cyclins, E2F and CIP/KIP-type Cdk
inhibitors. The work of Umen and Goodenough [8] even
suggests that Chlamydomonas has some sort of Rb control
mechanism similar to Rb mechanisms in animals. The
logical implication is that a D-type cyclin–Rb–E2F–cyclin
regulatory loop, and CIP/KIP inhibitors, may have existed
in the ancestral eukaryote, but that this loop was lost in
yeast lineages and replaced by yeast G1 cyclins and
Sic1/Rum1 Cdk inhibitors. 
Thus, Chlamydomonas has unique advantages for studying
Rb. Other eukaryotic microbes with better characterized
cell cycles lack Rb; and the very complex animal systems
are riddled with multiple Rb family members and overlap-
ping controls that may obscure important aspects of Rb
biology. A swimming single-celled plant may be a promis-
ing model system for cancer biology.
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